Literature DB >> 16819463

The gut flora as a forgotten organ.

Ann M O'Hara1, Fergus Shanahan.   

Abstract

The intestinal microflora is a positive health asset that crucially influences the normal structural and functional development of the mucosal immune system. Mucosal immune responses to resident intestinal microflora require precise control and an immunosensory capacity for distinguishing commensal from pathogenic bacteria. In genetically susceptible individuals, some components of the flora can become a liability and contribute to the pathogenesis of various intestinal disorders, including inflammatory bowel diseases. It follows that manipulation of the flora to enhance the beneficial components represents a promising therapeutic strategy. The flora has a collective metabolic activity equal to a virtual organ within an organ, and the mechanisms underlying the conditioning influence of the bacteria on mucosal homeostasis and immune responses are beginning to be unravelled. An improved understanding of this hidden organ will reveal secrets that are relevant to human health and to several infectious, inflammatory and neoplastic disease processes.

Entities:  

Mesh:

Year:  2006        PMID: 16819463      PMCID: PMC1500832          DOI: 10.1038/sj.embor.7400731

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  51 in total

1.  Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

Authors:  A S Neish; A T Gewirtz; H Zeng; A N Young; M E Hobert; V Karmali; A S Rao; J L Madara
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

2.  Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria.

Authors:  M Rescigno; M Urbano; B Valzasina; M Francolini; G Rotta; R Bonasio; F Granucci; J P Kraehenbuhl; P Ricciardi-Castagnoli
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

3.  Association of NOD2 with Crohn's disease in a homogenous Irish population.

Authors:  Emer Bairead; Dawn L Harmon; Anne M Curtis; Yvette Kelly; Clare O'Leary; Michelle Gardner; Dermot T Leahy; Pat Vaughan; Denise Keegan; Colm O'Morain; Diarmuid O'Donoghue; Fergus Shanahan; Nollaig A Parfrey; Kathleen A Quane
Journal:  Eur J Hum Genet       Date:  2003-03       Impact factor: 4.246

Review 4.  Tyrosine-phosphorylated bacterial effector proteins: the enemies within.

Authors:  Steffen Backert; Matthias Selbach
Journal:  Trends Microbiol       Date:  2005-10       Impact factor: 17.079

5.  Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.

Authors:  D A van Heel; S Ghosh; K A Hunt; C G Mathew; A Forbes; D P Jewell; R J Playford
Journal:  Gut       Date:  2005-05-31       Impact factor: 23.059

6.  Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.

Authors:  Masayuki Fukata; Kathrin S Michelsen; Rajaraman Eri; Lisa S Thomas; Bing Hu; Katie Lukasek; Cynthia C Nast; Juan Lechago; Ruliang Xu; Yoshikazu Naiki; Antoine Soliman; Moshe Arditi; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-05       Impact factor: 4.052

7.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

Review 8.  Conserved features of type III secretion.

Authors:  A P Tampakaki; V E Fadouloglou; A D Gazi; N J Panopoulos; M Kokkinidis
Journal:  Cell Microbiol       Date:  2004-09       Impact factor: 3.715

9.  NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.

Authors:  Tomohiro Watanabe; Atsushi Kitani; Peter J Murray; Warren Strober
Journal:  Nat Immunol       Date:  2004-06-27       Impact factor: 25.606

10.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

Authors:  Denise Kelly; Jamie I Campbell; Timothy P King; George Grant; Emmelie A Jansson; Alistair G P Coutts; Sven Pettersson; Shaun Conway
Journal:  Nat Immunol       Date:  2003-12-21       Impact factor: 25.606

View more
  736 in total

Review 1.  Diversity and function of the avian gut microbiota.

Authors:  Kevin D Kohl
Journal:  J Comp Physiol B       Date:  2012-01-14       Impact factor: 2.200

2.  Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype.

Authors:  Kyung-Won Hong; Kwang-Pil Ko; Younjhin Ahn; Cheong-Sik Kim; Seon-Joo Park; Jae Kyung Park; Sung Soo Kim; Yeonjung Kim
Journal:  Genes Nutr       Date:  2012-04-03       Impact factor: 5.523

Review 3.  Techniques used to characterize the gut microbiota: a guide for the clinician.

Authors:  Marianne H Fraher; Paul W O'Toole; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-27       Impact factor: 46.802

Review 4.  The potter's wheel: the host's role in sculpting its microbiota.

Authors:  Charles L Bevins; Nita H Salzman
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

5.  Shifting from a gene-centric to metabolite-centric strategy to determine the core gut microbiome.

Authors:  Julian R Marchesi
Journal:  Bioeng Bugs       Date:  2011-11-01

6.  Right colon, left colon, and rectal surgeries are not similar for surgical site infection development. Analysis of 277 elective and urgent colorectal resections.

Authors:  Luca Degrate; Mattia Garancini; Marta Misani; Silvia Poli; Cinzia Nobili; Fabrizio Romano; Laura Giordano; Vittorio Motta; Franco Uggeri
Journal:  Int J Colorectal Dis       Date:  2010-10-05       Impact factor: 2.571

7.  Anthropomorphism in science.

Authors:  Julian Davies
Journal:  EMBO Rep       Date:  2010-10       Impact factor: 8.807

Review 8.  The microbiome and regulation of mucosal immunity.

Authors:  Andrew J McDermott; Gary B Huffnagle
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

Review 9.  The CF gastrointestinal microbiome: Structure and clinical impact.

Authors:  Geraint B Rogers; Michael R Narkewicz; Lucas R Hoffman
Journal:  Pediatr Pulmonol       Date:  2016-10

10.  Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota.

Authors:  Mark W Musch; Yunwei Wang; Erika C Claud; Eugene B Chang
Journal:  Dig Dis Sci       Date:  2013-01-18       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.